Clinical Trial Detail

NCT ID NCT02848248
Title A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

acute myeloid leukemia

Therapies

SGN-CD123A

Age Groups: adult senior

No variant requirements are available.